Our Portfolio

Through OurCrowd’s investment platform, Dancap invested in SaNOtize, a life science therapeutics company that has developed a patented formulation that allows a safe, dose-controlled delivery of nitric oxide gas to the site of infection without gas cylinders. The technology shows efficacy for prevention and treatment of influenza and Covid-19. With antibiotic resistance increasing throughout the world and new Covid variants of concern being discovered, SaNOtize’s platform technology is an innovative and important tool in the fight against upper respiratory and topical infections.

Henry House at Clift Farm is a 273-unit luxury property in Huntsville, Alabama. This amenity-rich asset was built in 2021 and benefits from being located in one of the fastest growing high-tech job hubs in the country. The property’s leading amenity package combined with core location and apartment finishings, provide a powerful appeal to residents and investors alike.

Station on Peachtree, in Atlanta GA is a multifamily asset built in 2007 with tremendous value-add potential. The objective is to purchase, rent or lease, manage, and improve this 192-unit property. The property benefits from being immersed in the boutique Chamblee neighborhood, offering exceptional walkability to chic eateries and retail.

Remilk uses a technique known as precision fermentation from a recombinant source (DNA molecules formed by laboratory methods of genetic recombination to bring together genetic material from multiple sources) in order to synthetically produce casein micelles in powder form. Remilk’s target customers are dairy food processors, who will then add water, oils, and vegetable sugars to their product in order to produce cheeses identical in performance, appearance, and taste to those of conventional dairy foods.

Through OurCrowd’s investment platform, Dancap invested in Eko Devices Inc. Eko develops cardiac screening devices, care coordination software, and interpretive algorithms to enable better monitoring and management of cardiovascular diseases. Eko’s algorithms have a >85% accuracy as compared to 20-50% for alternative methods, resulting in faster diagnosis, optimal treatments, and superior outcomes.

Foretellix is enabling the digital transformation of safety-critical automotive verification. Foretellix’s solutions uniquely scale to meet the challenge of verifying the safety of today’s increasingly complex automated driving systems. The platform orchestrates and manages the massive scale of testing required to ensure safety, reduce development costs, and shorten the time to market of Automated Driving Systems deployment. Foretellix is led by an experienced team of professionals possessing decades of expertise developing advanced verification solutions, as well as proven track records deploying verification solutions at leading semiconductor companies.

Through OurCrowd’s investment platform, Dancap invested in Innovalve, a biomedical startup that is developing a Transcatheter Mitral Valve Replacement solution. Today, the only means of replacing a diseased mitral valve is by highly-invasive open-heart surgery. The device hopes to enable a simple, fast and safe catheter-based mitral valve replacement, yielding better clinical outcomes for a much larger patient population.

Through OurCrowd’s investment platform, Dancap invested in Hailo’s technology, which has developed an optimized processor for deep learning workloads, which it believes delivers unprecedented performance to edge devices. Hailo reports that its chip is built with an innovative architecture that enables edge devices to run sophisticated deep learning applications faster, while consuming less energy and with lower cost than currently available solutions.

The Fund’s objective is to primarily acquire lands in the Greater Toronto Area and develop these lands by rezoning and constructing low-rise and mid/high-rise residences and that may include ancillary retail, office or other commercial components. Lands that will be acquired will most often require rezoning and once rezoned, the Fund may or may not construct, at its discretion.

The Carlyle Group is a global private equity firm headquartered in Washington D.C. Carlyle Japan International Partners IV will seek to invest in upper middle-market opportunities across Japan, focusing on carve-outs and succession investments. The team’s dedicated local presence and flexibility to execute on larger investments provides significant access to proprietary opportunities, while the Global One Carlyle platform enables transformative value creation plans to be implemented.

Bridge Office Fund II International-A L.P. aims to assemble a diversified portfolio of existing commercial office properties that offer strong, current and projected income with an expectation of capital appreciation. The fund will create alpha at the asset level by transforming unit interiors and common areas; increasing tenant satisfaction; and adding profound social and community program amenities, all to achieve strong occupancy and rent growth.

The Resolute Fund V, L.P. will primarily target control private equity investments and strive to create a diversified portfolio of established, well-managed and profitable middle-market businesses, located principally in North America. TJC’s investment strategy is to acquire companies in partnership with management andto support these investments with a hands-on approach which includes strategic acquisitions and valued-added operational strategies that The Jordan Company believes will generate strong investment returns.